{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:59Z","timestamp":1791928679994,"version":"4.3.4"},"reference-count":38,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"11","license":[{"start":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T00:00:00Z","timestamp":1537833600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,9,25]]},"DOI":"10.1167\/iovs.18-24630","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T03:38:45Z","timestamp":1538192325000},"page":"4662","source":"Crossref","is-referenced-by-count":12,"title":["Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease"],"prefix":"10.1167","volume":"59","author":[{"given":"Shenglan","family":"Yi","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Hu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiguo","family":"Qiu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gangxiang","family":"Yuan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aize","family":"Kijlstra","sequence":"additional","affiliation":[{"name":"University Eye Clinic Maastricht, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology and Chongqing Eye Institute, Chongqing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-11-4662-b01","doi-asserted-by":"crossref","unstructured":"Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005; 30: 943\u2013948.","DOI":"10.1080\/02713680500263606"},{"key":"i1552-5783-59-11-4662-b02","doi-asserted-by":"crossref","unstructured":"Ohguro N, Sonoda KH, Takeuchi M, Matsumura M, Mochizuki M. The 2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012; 56: 432\u2013435.","DOI":"10.1007\/s10384-012-0158-z"},{"key":"i1552-5783-59-11-4662-b03","doi-asserted-by":"crossref","unstructured":"Yang P, Du L, Ye Z. How To deal with uveitis patients? Curr Mol Med. 2018; 17: 468\u2013470.","DOI":"10.2174\/1566524018666180207153342"},{"key":"i1552-5783-59-11-4662-b04","doi-asserted-by":"crossref","unstructured":"Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016; 52: 84\u2013111.","DOI":"10.1016\/j.preteyeres.2016.02.002"},{"key":"i1552-5783-59-11-4662-b05","doi-asserted-by":"crossref","unstructured":"Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007; 114: 606\u2013614.","DOI":"10.1016\/j.ophtha.2006.07.040"},{"key":"i1552-5783-59-11-4662-b06","doi-asserted-by":"crossref","unstructured":"Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995; 39: 265\u2013292.","DOI":"10.1016\/S0039-6257(05)80105-5"},{"key":"i1552-5783-59-11-4662-b07","doi-asserted-by":"crossref","unstructured":"Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease. J Allergy Clin Immunol. 2007; 119: 1218\u20131224.","DOI":"10.1016\/j.jaci.2007.01.010"},{"key":"i1552-5783-59-11-4662-b08","doi-asserted-by":"crossref","unstructured":"Yang Y, Qi J, Wang Q, et al. Berberine suppresses Th17 and dendritic cell responses. Invest Ophthalmol Vis Sci. 2013; 54: 2516\u20132522.","DOI":"10.1167\/iovs.12-11217"},{"key":"i1552-5783-59-11-4662-b09","doi-asserted-by":"crossref","unstructured":"Wu L, Wen H, Zhou Y, et al. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease. Curr Mol Med. 2014; 14: 712\u2013722.","DOI":"10.2174\/1566524014666140724100135"},{"key":"i1552-5783-59-11-4662-b10","doi-asserted-by":"crossref","unstructured":"Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012; 30: 1\u201322.","DOI":"10.1146\/annurev-immunol-100311-102839"},{"key":"i1552-5783-59-11-4662-b11","doi-asserted-by":"crossref","unstructured":"Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007; 117: 1119\u20131127.","DOI":"10.1172\/JCI31720"},{"key":"i1552-5783-59-11-4662-b12","doi-asserted-by":"crossref","unstructured":"Flores-Romo L. In vivo maturation and migration of dendritic cells. Immunology. 2001; 102: 255\u2013262.","DOI":"10.1046\/j.1365-2567.2001.01204.x"},{"key":"i1552-5783-59-11-4662-b13","doi-asserted-by":"crossref","unstructured":"Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000; 18: 767\u2013811.","DOI":"10.1146\/annurev.immunol.18.1.767"},{"key":"i1552-5783-59-11-4662-b14","doi-asserted-by":"crossref","unstructured":"Tsujimura H, Tamura T, Kong HJ, et al. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8\/IFN consensus sequence binding protein in dendritic cells. J Immunol. 2004; 172: 6820\u20136827.","DOI":"10.4049\/jimmunol.172.11.6820"},{"key":"i1552-5783-59-11-4662-b15","doi-asserted-by":"crossref","unstructured":"Eriksson U, Ricci R, Hunziker L, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. 2003; 9: 1484\u20131490.","DOI":"10.1038\/nm960"},{"key":"i1552-5783-59-11-4662-b16","doi-asserted-by":"crossref","unstructured":"Ahmed MS, Byeon SE, Jeong Y, et al. Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy. Oncoimmunology. 2015; 4: e984550.","DOI":"10.4161\/2162402X.2014.984550"},{"key":"i1552-5783-59-11-4662-b17","doi-asserted-by":"crossref","unstructured":"Lin W, Wang W, Wang D, Ling W. Quercetin protects against atherosclerosis by inhibiting dendritic cell activation [published online ahead of print April 29, 2017]. Mol Nutr Food Res. https:\/\/doi.org\/10.1002\/mnfr.201700031.","DOI":"10.1002\/mnfr.201700031"},{"key":"i1552-5783-59-11-4662-b18","doi-asserted-by":"crossref","unstructured":"Tong JH, Ng DC, Chau SL, et al. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer. 2010; 10: 253.","DOI":"10.1186\/1471-2407-10-253"},{"key":"i1552-5783-59-11-4662-b19","doi-asserted-by":"crossref","unstructured":"Tian X, Zhang Z. miR-191\/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. IUBMB Life. 2018; 70: 71\u201380.","DOI":"10.1002\/iub.1705"},{"key":"i1552-5783-59-11-4662-b20","doi-asserted-by":"crossref","unstructured":"Jain N, Nguyen H, Friedline RH, et al. Cutting edge: Dab2 is a FOXP3 target gene required for regulatory T cell function. J Immunol. 2009; 183: 4192\u20134196.","DOI":"10.4049\/jimmunol.0902041"},{"key":"i1552-5783-59-11-4662-b21","doi-asserted-by":"crossref","unstructured":"Adamson SE, Griffiths R, Moravec R, et al. Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation. J Clin Invest. 2016; 126: 1311\u20131322.","DOI":"10.1172\/JCI79590"},{"key":"i1552-5783-59-11-4662-b22","doi-asserted-by":"crossref","unstructured":"Jokubaitis VG, Gresle MM, Kemper DA, et al. Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis. Acta Neuropathol Commun. 2013; 1: 32.","DOI":"10.1186\/2051-5960-1-32"},{"key":"i1552-5783-59-11-4662-b23","doi-asserted-by":"crossref","unstructured":"Ahn M, Oh H, Lee W, Kim H, Moon C, Shin T. Immunohistochemical studies on disabled-2 protein in the spinal cords of rats with experimental autoimmune encephalomyelitis. Brain Res. 2011; 1416: 51\u201360.","DOI":"10.1016\/j.brainres.2011.08.009"},{"key":"i1552-5783-59-11-4662-b24","doi-asserted-by":"crossref","unstructured":"Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity. 2010; 105: 4\u201313.","DOI":"10.1038\/hdy.2010.54"},{"key":"i1552-5783-59-11-4662-b25","doi-asserted-by":"crossref","unstructured":"Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004; 429: 457\u2013463.","DOI":"10.1038\/nature02625"},{"key":"i1552-5783-59-11-4662-b26","doi-asserted-by":"crossref","unstructured":"Bagadi SA, Prasad CP, Srivastava A, Prashad R, Gupta SD, Ralhan R. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat. 2007; 104: 277\u2013286.","DOI":"10.1007\/s10549-006-9422-6"},{"key":"i1552-5783-59-11-4662-b27","doi-asserted-by":"crossref","unstructured":"Sun B, Hu L, Luo ZY, Chen XP, Zhou HH, Zhang W. DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clin Immunol. 2016; 164: 21\u201327.","DOI":"10.1016\/j.clim.2016.01.011"},{"key":"i1552-5783-59-11-4662-b28","doi-asserted-by":"crossref","unstructured":"Guo Q, Wu D, Yu H, et al. Alterations of global DNA methylation and DNA methyltransferase expression in T and B lymphocytes from patients with newly diagnosed autoimmune thyroid diseases after treatment: a follow-up study. Thyroid. 2018; 28: 377\u2013385.","DOI":"10.1089\/thy.2017.0301"},{"key":"i1552-5783-59-11-4662-b29","doi-asserted-by":"crossref","unstructured":"Luo Y, Li Y, Su Y, et al. Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. Br J Dermatol. 2008; 159: 827\u2013833.","DOI":"10.1111\/j.1365-2133.2008.08758.x"},{"key":"i1552-5783-59-11-4662-b30","doi-asserted-by":"crossref","unstructured":"Zhu Y, Yu H, Qiu Y, et al. Promoter hypermethylation of GATA3, IL-4, and TGF-beta confers susceptibility to Vogt-Koyanagi-Harada disease in Han Chinese. Invest Ophthalmol Vis Sci. 2017; 58: 1529\u20131536.","DOI":"10.1167\/iovs.16-21188"},{"key":"i1552-5783-59-11-4662-b31","doi-asserted-by":"crossref","unstructured":"Qiu Y, Yu H, Zhu Y, et al. Hypermethylation of interferon regulatory factor 8 (IRF8) confers risk to Vogt-Koyanagi-Harada disease. Sci Rep. 2017; 7: 1007.","DOI":"10.1038\/s41598-017-01249-7"},{"key":"i1552-5783-59-11-4662-b32","doi-asserted-by":"crossref","unstructured":"Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001; 131: 647\u2013652.","DOI":"10.1016\/S0002-9394(01)00925-4"},{"key":"i1552-5783-59-11-4662-b33","doi-asserted-by":"crossref","unstructured":"Yang P, Ye Z, Du L, et al. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018; 43: 254\u2013261.","DOI":"10.1080\/02713683.2017.1383444"},{"key":"i1552-5783-59-11-4662-b34","doi-asserted-by":"crossref","unstructured":"Ghislat G, Lawrence T. Autophagy in dendritic cells [published online ahead of print March 26, 2018]. Cell Mol Immunol. http:\/\/dx.doi.org\/10.1038\/cmi.2018.2.","DOI":"10.1038\/cmi.2018.2"},{"key":"i1552-5783-59-11-4662-b35","doi-asserted-by":"crossref","unstructured":"Parekh VV, Pabbisetty SK, Wu L, et al. Autophagy-related protein Vps34 controls the homeostasis and function of antigen cross-presenting CD8alpha(+) dendritic cells. Proc Natl Acad Sci U S A. 2017; 114: E6371\u2013E6380.","DOI":"10.1073\/pnas.1706504114"},{"key":"i1552-5783-59-11-4662-b36","doi-asserted-by":"crossref","unstructured":"Jiang Y, Woosley AN, Sivalingam N, Natarajan S, Howe PH. Cathepsin-B-mediated cleavage of Disabled-2 regulates TGF-beta-induced autophagy. Nat Cell Biol. 2016; 18: 851\u2013863.","DOI":"10.1038\/ncb3388"},{"key":"i1552-5783-59-11-4662-b37","doi-asserted-by":"crossref","unstructured":"De la Cruz-Mosso U, Garcia-Iglesias T, Bucala R, et al. MIF promotes a differential Th1\/Th2\/Th17 inflammatory response in human primary cell cultures: predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-alpha in PBMC from active SLE patients. Cell Immunol. 2018; 324: 42\u201349.","DOI":"10.1016\/j.cellimm.2017.12.010"},{"key":"i1552-5783-59-11-4662-b38","doi-asserted-by":"crossref","unstructured":"Chang R, Yi S, Tan X, et al. MicroRNA-20a-5p suppresses IL-17 production by targeting OSM and CCL1 in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2018; 102: 282\u2013290.","DOI":"10.1136\/bjophthalmol-2017-311079"}],"container-title":["Investigative Opthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2704849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:57Z","timestamp":1791927057000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-24630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,25]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,9,4]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-24630","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,25]]}}}